Track topics on Twitter Track topics that are important to you
Regeneron chief scientific officer George Yancopoulos commented: “with today's FDA approval, Eylea has once again set a high bar for the treatment of diabetic eye diseases.”NEXT ARTICLE
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...